Can you provide the average price target for SEMPRA stock?
23 analysts have analysed SRE and the average price target is 104.64 USD. This implies a price increase of 9.23% is expected in the next year compared to the current price of 95.79.
NYSE:SRE • US8168511090
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SEMPRA (SRE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-15 | Barclays | Maintains | Overweight -> Overweight |
| 2026-03-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-03-06 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-03-04 | Argus Research | Upgrade | Hold -> Buy |
| 2026-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-03 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-22 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-22 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-24 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-14 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-28 | Wells Fargo | Initiate | Overweight |
| 2025-10-22 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-10-22 | Jefferies | Maintains | Hold -> Hold |
| 2025-10-20 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-10-07 | Evercore ISI Group | Initiate | Outperform |
| 2025-09-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-09-24 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.72B 15.80% | 13.185B -21.14% | 13.702B 3.92% | 14.495B 5.79% | 13.946B -3.79% | 14.326B 2.72% | 15.338B 7.06% | 13.715B -10.58% | |
| EBITDA YoY % growth | 5.942B 29.85% | 5.399B -9.14% | 5.643B 4.52% | 6.271B 11.13% | 6.153B -1.88% | 6.518B 5.93% | 7.301B 12.01% | 7.554B 3.47% | |
| EBIT YoY % growth | 3.715B 45.29% | 2.962B -20.27% | 3.08B 3.98% | 3.569B 15.88% | 3.551B -0.50% | 3.833B 7.94% | 3.771B -1.62% | 3.646B -3.31% | |
| Operating Margin | 22.22% | 22.46% | 22.48% | 24.62% | 25.46% | 26.76% | 24.59% | 26.58% | |
| EPS YoY % growth | 4.61 0.11% | 4.62 0.22% | 4.72 2.16% | 5.15 9.21% | 5.56 7.87% | 6.05 8.82% | 6.63 9.60% | 7.22 8.88% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.53 5.95% | 1.00 12.46% | 1.01 -8.78% | 1.65 28.90% | 1.62 5.93% | 1.02 1.80% | 1.00 -1.73% | 1.92 16.62% | 1.78 9.88% | 1.10 7.95% | 0.96 -3.10% | 2.18 13.36% |
| Revenue Q2Q % growth | 4.129B 8.60% | 2.976B -0.80% | 2.614B -17.04% | 4.721B 25.93% | 4.082B -1.14% | 2.077B -30.21% | 346.88M -86.73% | 7.307B 54.78% | 4.293B 5.17% | 2.185B 5.20% | 364.89M 5.19% | 7.686B 5.19% |
| EBITDA Q2Q % growth | 1.814B 13.45% | 1.452B -22.64% | 1.438B -41.35% | 1.791B -50.29% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.064B 10.95% | 683.5M 17.04% | 821.53M 65.30% | 1.316B 26.54% | 823.86M -22.57% | 419.2M -38.67% | 70.023M -91.48% | 1.475B 12.08% | 957.74M 16.25% | 487.33M 16.25% | 81.396M 16.24% | 1.715B 16.27% |
All data in USD
23 analysts have analysed SRE and the average price target is 104.64 USD. This implies a price increase of 9.23% is expected in the next year compared to the current price of 95.79.
SEMPRA (SRE) will report earnings on 2026-04-30, before the market open.
The consensus EPS estimate for the next earnings of SEMPRA (SRE) is 1.53 USD and the consensus revenue estimate is 4.13B USD.
The expected long term growth rate for SEMPRA (SRE) is 0.71%.